Aethlon Medical Inc has a consensus price target of $5, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Maxim Group on March 4, 2024, October 24, 2023, and November 15, 2022. With an average price target of $11 between HC Wainwright & Co., HC Wainwright & Co., and Maxim Group, there's an implied 653.42% upside for Aethlon Medical Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/04/2024 | AEMD | Buy Now | Aethlon Medical | $1.46 | 584.93% | HC Wainwright & Co. | Vernon Bernardino | $23 → $10 | Maintains | Buy | Get Alert |
10/24/2023 | AEMD | Buy Now | Aethlon Medical | $1.46 | 1475.34% | HC Wainwright & Co. | Vernon Bernardino | $90 → $23 | Maintains | Buy | Get Alert |
11/15/2022 | AEMD | Buy Now | Aethlon Medical | $1.46 | — | Maxim Group | Anthony Vendetti | — | Downgrade | Buy → Hold | Get Alert |
06/25/2021 | AEMD | Buy Now | Aethlon Medical | $1.46 | 516.44% | HC Wainwright & Co. | Vernon Bernardino | — | Maintains | Buy | Get Alert |
06/01/2021 | AEMD | Buy Now | Aethlon Medical | $1.46 | 242.47% | HC Wainwright & Co. | Vernon Bernardino | — | Initiates | → Buy | Get Alert |
The latest price target for Aethlon Medical (NASDAQ: AEMD) was reported by HC Wainwright & Co. on March 4, 2024. The analyst firm set a price target for $10.00 expecting AEMD to rise to within 12 months (a possible 584.93% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Aethlon Medical (NASDAQ: AEMD) was provided by HC Wainwright & Co., and Aethlon Medical maintained their buy rating.
There is no last upgrade for Aethlon Medical.
The last downgrade for Aethlon Medical Inc happened on November 15, 2022 when Maxim Group changed their price target from N/A to N/A for Aethlon Medical Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aethlon Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aethlon Medical was filed on March 4, 2024 so you should expect the next rating to be made available sometime around March 4, 2025.
While ratings are subjective and will change, the latest Aethlon Medical (AEMD) rating was a maintained with a price target of $23.00 to $10.00. The current price Aethlon Medical (AEMD) is trading at is $1.46, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.